Sunesis Pharma Climbs After Viracta Poised To Nab US Patent For Nanatinostat/Valganciclovir Regime – Benzinga
Sunesis Pharma Climbs After Viracta Poised To Nab US Patent For Nanatinostat/Valganciclovir Regime Benzinga
In: PATENT NEWS
Sunesis Pharma Climbs After Viracta Poised To Nab US Patent For Nanatinostat/Valganciclovir Regime Benzinga
In: PATENT NEWS
Ford Wins Agency Tribunal Challenge to MIT Clean Engine Patents · More from Bloomberg Law.
In: PATENT NEWS
Meredith Lowry, patent attorney, Wright, Lindsey & Jennings LLP; Bjorn Simmons, co-founder and managing partner, Venture Noire; Maf Sonko, co- …
In: PATENT NEWS
Several new intellectual property statutes were signed into law as part of the COVID-19 relief legislation passed in December 2 … February 15, 2021 – By …
In: PATENT NEWS
This makes it a very unorthodox rule from an international tax law … However, such agreements often include a variety of IP rights (e.g. without any …
In: PATENT NEWS
Case: Patents/Obviousness (PTAB) Bloomberg Law
In: PATENT NEWS
Windtree Therapeutics’ AEROSURF Drug Delivery Device Secures US Patent Benzinga
In: PATENT NEWS
On 27 January 2021, the German Parliament discussed a draft law that would limit a patent owner’s ability to stop the production and distribution of an …
In: PATENT NEWS
What is the intellectual property rights landscape surrounding innovative … Berkeley Center for Law & Technology, Asia Intellectual Property Project; …
In: PATENT NEWS
Patent Directed to Countering Credit Card Fraud is an Invalid Abstract Idea Under Section 101 JD Supra
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION